Mersana Therapeutics, Inc. (MRSN) Revenue by Year
Mersana Therapeutics, Inc. generated $40.5M in revenue in fiscal year 2024. This represents an increase of 9.9% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to $33.2M in revenue. The table below carries 10 fiscal years, from 2015 to 2024, and the quarters Mersana Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MRSN Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
MRSN Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Mersana Therapeutics, Inc. financials
Frequently Asked Questions
What was Mersana Therapeutics, Inc.'s revenue in fiscal year 2024?
Mersana Therapeutics, Inc. generated $40.5M in revenue in fiscal year 2024.
How fast is Mersana Therapeutics, Inc.'s revenue growing?
Mersana Therapeutics, Inc. (MRSN) revenue rose by 9.9% year over year, from $36.9M to $40.5M in fiscal year 2024.
What is Mersana Therapeutics, Inc.'s revenue over the last twelve months?
Mersana Therapeutics, Inc. (MRSN) reported $33.2M in revenue over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
How has Mersana Therapeutics, Inc.'s revenue changed over the years?
Across the 10 fiscal years this page covers, Mersana Therapeutics, Inc. (MRSN) revenue went from $10.4M in fiscal year 2015 to $40.5M in fiscal year 2024.
What was Mersana Therapeutics, Inc.'s revenue in the most recent quarter?
Mersana Therapeutics, Inc. (MRSN) reported $11.0M in revenue in Q3 2025. This represents a decrease of 12.6% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Mersana Therapeutics, Inc. (MRSN) reported on that line in every period on record.